Works matching IS 00070920 AND DT 2023 AND VI 129 AND IP 2

Results: 18

Whole-exome and targeted gene sequencing of large-cell lung carcinoma reveals recurrent mutations in the PI3K pathway.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 366, doi. 10.1038/s41416-023-02301-2

By:

Guo, Jun-Hong;
Ma, Yu-Shui;
Lin, Jie-Wei;
Jiang, Geng-Xi;
He, Juan;
Lu, Hai-Min;
Wu, Wei;
Diao, Xun;
Fan, Qi-Yu;
Wu, Chun-Yan;
Liu, Ji-Bin;
Fu, Da;
Hou, Li-Kun

Publication type:

Article

Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 374, doi. 10.1038/s41416-023-02300-3

By:

Ryoo, Seung-Bum;
Heo, Sunghoon;
Lim, Yoojoo;
Lee, Wookjae;
Cho, Su Han;
Ahn, Jongseong;
Kang, Jun-Kyu;
Kim, Su Yeon;
Kim, Hwang-Phill;
Bang, Duhee;
Kang, Sung-Bum;
Yu, Chang Sik;
Oh, Seong Taek;
Park, Ji Won;
Jeong, Seung-Yong;
Kim, Young-Joon;
Park, Kyu Joo;
Han, Sae-Won;
Kim, Tae-You

Publication type:

Article

Neighbourhood social deprivation and risk of prostate cancer.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 335, doi. 10.1038/s41416-023-02299-7

By:

Salmon, Charlotte;
Quesnel-Vallée, Amélie;
Barnett, Tracie A.;
Benedetti, Andrea;
Cloutier, Marie-Soleil;
Datta, Geetanjali D.;
Kestens, Yan;
Nicolau, Belinda;
Parent, Marie-Élise

Publication type:

Article

Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 291, doi. 10.1038/s41416-023-02298-8

By:

Raj, Nitya;
Chan, Jennifer A.;
Wang, Stephanie J.;
Aggarwal, Rahul R.;
Calabrese, Susan;
DeMore, April;
Fong, Lawrence;
Grabowsky, Jennifer;
Hope, Thomas A.;
Kolli, Kanti Pallav;
Mulvey, Claire K.;
Munster, Pamela N.;
Perez, Kimberly;
Punn, Sippy;
Reidy-Lagunes, Diane;
Von Fedak, Sofia;
Zhang, Li;
Bergsland, Emily K.

Publication type:

Article

Cost-effectiveness analysis of molecular testing in minimally invasive samples to detect endometrial cancer in women with postmenopausal bleeding.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 325, doi. 10.1038/s41416-023-02291-1

By:

Peremiquel-Trillas, Paula;
Gómez, David;
Martínez, José Manuel;
Fernández-González, Sergi;
Frias-Gomez, Jon;
Paytubi, Sonia;
Pelegrina, Beatriz;
Pineda, Marta;
Brunet, Joan;
Ponce, Jordi;
Matias-Guiu, Xavier;
Bosch, Xavier;
de Sanjosé, Silvia;
Bruni, Laia;
Alemany, Laia;
Costas, Laura;
Díaz, Mireia

Publication type:

Article

Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance).

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 283, doi. 10.1038/s41416-023-02290-2

By:

Lee, Seohyuk;
Ma, Chao;
Shi, Qian;
Meyers, Jeffrey;
Kumar, Pankaj;
Couture, Felix;
Kuebler, Philip;
Krishnamurthi, Smitha;
Lewis, DeQuincy;
Tan, Benjamin;
O'Reilly, Eileen M.;
Shields, Anthony F.;
Meyerhardt, Jeffrey A.

Publication type:

Article

Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 346, doi. 10.1038/s41416-023-02283-1

By:

Langlais, Crystal S.;
Graff, Rebecca E.;
Van Blarigan, Erin L.;
Neuhaus, John M.;
Cowan, Janet E.;
Broering, Jeanette M.;
Carroll, Peter;
Kenfield, Stacey A.;
Chan, June M.

Publication type:

Article

Targeting metabolism by B-raf inhibitors and diclofenac restrains the viability of BRAF-mutated thyroid carcinomas with Hif-1α-mediated glycolytic phenotype.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 249, doi. 10.1038/s41416-023-02282-2

By:

Aprile, Marianna;
Cataldi, Simona;
Perfetto, Caterina;
Federico, Antonio;
Ciccodicola, Alfredo;
Costa, Valerio

Publication type:

Article

Maternal and childhood medical history and the risk of childhood brain tumours: a case–control study in Ontario, Canada.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 318, doi. 10.1038/s41416-023-02281-3

By:

Cheng, Sierra;
McLaughlin, John R.;
Brown, M. Catherine;
Al-Sawaihey, Hamad;
Rutka, James;
Bouffet, Eric;
Hawkins, Cynthia;
Cairney, A. Elizabeth;
Ranger, Adrianna;
Fleming, Adam J.;
Johnston, Donna;
Grenberg, Mark;
Malkin, David;
Hung, Rayjean J.

Publication type:

Article

Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, and clinical activity of OBI-3424 in patients with advanced or metastatic solid tumors.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 266, doi. 10.1038/s41416-023-02280-4

By:

Tsimberidou, Apostolia Maria;
Verschraegen, Claire F.;
Wesolowski, Robert;
Shia, Chi-Sheng;
Hsu, Pei;
Pearce, Tillman E.

Publication type:

Article

NDRG1 facilitates self-renewal of liver cancer stem cells by preventing EpCAM ubiquitination.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 237, doi. 10.1038/s41416-023-02278-y

By:

Cheng, Qian;
Ning, Shanglei;
Zhu, Lei;
Zhang, Changlu;
Jiang, Shaodong;
Hao, Yajing;
Zhu, Jiye

Publication type:

Article

Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 309, doi. 10.1038/s41416-023-02276-0

By:

El-Khoueiry, Anthony B.;
Clarke, James;
Neff, Tobias;
Crossman, Tim;
Ratia, Nirav;
Rathi, Chetan;
Noto, Paul;
Tarkar, Aarti;
Garrido-Laguna, Ignacio;
Calvo, Emiliano;
Rodón, Jordi;
Tran, Ben;
O'Dwyer, Peter J.;
Cuker, Adam;
Abdul Razak, Albiruni R.

Publication type:

Article

RNA modifications in cancer.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 204, doi. 10.1038/s41416-023-02275-1

By:

Tang, Qiling;
Li, Lvyuan;
Wang, Yumin;
Wu, Pan;
Hou, Xiangchan;
Ouyang, Jiawei;
Fan, Chunmei;
Li, Zheng;
Wang, Fuyan;
Guo, Can;
Zhou, Ming;
Liao, Qianjin;
Wang, Hui;
Xiang, Bo;
Jiang, Weihong;
Li, Guiyuan;
Zeng, Zhaoyang;
Xiong, Wei

Publication type:

Article

A randomised phase 2 study of continuous or intermittent dosing schedule of imatinib re-challenge in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumours.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 275, doi. 10.1038/s41416-023-02269-z

By:

Kim, Hyung-Don;
Yoo, Changhoon;
Ryu, Min-Hee;
Kang, Yoon-Koo

Publication type:

Article

What do women think about having received their breast cancer risk as part of a risk-stratified NHS Breast Screening Programme? A qualitative study.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 356, doi. 10.1038/s41416-023-02268-0

By:

McWilliams, Lorna;
Ruane, Helen;
Ulph, Fiona;
Woof, Victoria G.;
Harrison, Fiona;
Evans, D. Gareth;
French, David P.

Publication type:

Article

HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 222, doi. 10.1038/s41416-023-02266-2

By:

Formica, Vincenzo;
Riondino, Silvia;
Morelli, Cristina;
Guerriero, Simona;
D'Amore, Federica;
Di Grazia, Antonio;
Del Vecchio Blanco, Giovanna;
Sica, Giuseppe;
Arkenau, Hendrik-Tobias;
Monteleone, Giovanni;
Roselli, Mario

Publication type:

Article

Six-year experience of Australia's first dedicated cancer of unknown primary clinic.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 301, doi. 10.1038/s41416-023-02254-6

By:

van Mourik, Arielle;
Tonkin-Hill, Gina;
O'Farrell, John;
Waller, Shohei;
Tan, Lavinia;
Tothill, Richard W.;
Bowtell, David;
Fox, Stephen;
Fellowes, Andrew;
Fedele, Clare;
Schofield, Penelope;
Sivakumaran, Tharani;
Wong, Hui-Li;
Mileshkin, Linda

Publication type:

Article

Involvement of the kynurenine pathway in breast cancer: updates on clinical research and trials.

Published in:

British Journal of Cancer, 2023, v. 129, n. 2, p. 185, doi. 10.1038/s41416-023-02245-7

By:

Girithar, Hemaasri-Neya;
Staats Pires, Ananda;
Ahn, Seong Beom;
Guillemin, Gilles J.;
Gluch, Laurence;
Heng, Benjamin

Publication type:

Article